Browsing: Investments
The Lotteries and Gaming Board in Zimbabwe plans to tighten regulatory controls over the betting industry to address concerns about illegal activities, financial crimes, and the social impact of gambling addiction.
Discover the significant job losses in Zimbabwe’s mining sector, the reasons behind them, and the government’s inaction. Learn about the challenges faced by workers and the uncertain future ahead.
Government revenue at the Beitbridge Border Post has surged significantly after its modernisation, demonstrating the impact of public-private partnerships (PPPs) on infrastructure-led growth in Zimbabwe and beyond.
ZHH & Robin LLP China (ZHH) and Mohamed Ridza & Co Malaysia (MRCO) signed an agreement to strengthen legal connection along the Malaysia-China business corridor, enhancing legal services for clients in both jurisdictions.
Five years after George Floyd’s murder, the fight for racial justice continues despite challenges and setbacks in corporate America and government support. Learn about the ongoing efforts and the impact on the movement.
Walmart Inc. CEO sells $2,815,113.84 worth of stock. Analysis of the transaction, stock performance, dividend announcement, and analyst ratings. Institutional investments in Walmart.
Nvidia is set to launch a new, more affordable Blackwell AI chip for China in response to US export restrictions. Learn about the specifications and market impact of this latest development.
Quantinno Funding Administration LP increased its holdings in iShares MSCI Australia ETF by 11.2% in the 4th quarter. Explore the company’s latest 13F filing and the impact on the exchange traded fund’s supply.
The Justice Department reaches a deal with Boeing to avoid prosecution for deceiving regulators over the 737 Max crashes. Boeing agrees to pay over $1.1 billion.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Kymera Therapeutics Inc. by 7.5% in the 4th quarter according to the latest SEC filing. Learn about institutional investors changes and insider trading at Kymera Therapeutics.